Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Micah Buckel

Physician Assistant, Medical Lexington, KY Physician Assistant

NPI 1902200413 CMS profile 10648403

2108 Nicholasville Rd, Lexington, KY 40503

Open in the dashboard

General payments

$7,065

396 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Micah Buckel of Lexington, KY is reported in the CMS Open Payments database as having received $7,065 across 396 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,426 76
2024 General $1,860 103
2023 General $1,461 89
2022 General $1,137 57
2021 General $1,180 71

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Micah Buckel
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Micah Buckel were reported at $1,426. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Micah Buckel Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $1,180 $156 $41–$563 $132
2022 $1,137 $185 $55–$649 $149
2023 $1,461 $199 $58–$717 $160
2024 $1,860 $206 $62–$740 $164
2025 $1,426 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Lilly USA, LLC $1,074 65 payments
  2. Novo Nordisk Inc $986 49 payments
  3. Pfizer Inc. $756 55 payments
  4. AbbVie, Inc. $541 31 payments
  5. AstraZeneca Pharmaceuticals LP $511 18 payments
  6. Boehringer Ingelheim Pharmaceuticals, Inc. $458 32 payments
  7. Merck Sharp & Dohme Corporation $336 21 payments
  8. Esperion Therapeutics, Inc. $318 7 payments
  9. Exact Sciences Corporation $215 15 payments
  10. Antares Pharma, Inc. $193 6 payments
  11. Other $1,676 97 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $7,052 395 payments
  2. Education $12 1 payment
Products named General payments · program years 2021–2025
  1. MOUNJARO $842 49 payments
  2. NURTEC ODT $593 44 payments
  3. Ozempic $456 27 payments
  4. AIRSUPRA $410 11 payments
  5. NEXLETOL $318 7 payments
  6. FARXIGA $307 7 payments
  7. ZAVZPRET $301 20 payments
  8. VRAYLAR $300 18 payments
  9. RYBELSUS $263 11 payments
  10. Wegovy $253 10 payments
  11. Other $5,601 327 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 78 drugs

Part D claims

2,805

Median for Physician Assistant: 241

Drug cost

$236,108

Median for Physician Assistant: $4,110

Branded share of claims

16.8%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ozempic Semaglutide Brand 39 $54,713
Jardiance Empagliflozin Brand 42 $44,319
Eliquis Apixaban Brand 31 $35,699
Mounjaro Tirzepatide Brand 27 $27,362
Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog Brand 23 $17,187
Anoro Ellipta Umeclidinium Brm/Vilanterol Tr Brand 16 $12,110
Tresiba Flextouch U-200 Insulin Degludec Brand 11 $12,005
Lantus Solostar Insulin Glargine,hum.Rec.Anlog Brand 17 $1,847
Insulin Lispro Kwikpen U-100 Insulin Lispro Brand 14 $1,783
Pravastatin Sodium Generic 132 $1,562

The 10 drugs with the highest cost, of 78 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 31 billing codes

Paid by Medicare

$35,458

Of which drugs: $3,825

Medicare patients

150

Average age 74

Services billed

606

78 women, 72 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 52%
Diabetes 31%
Chronic kidney disease 26%
Ischemic heart disease 23%
Depression 20%
Osteoporosis 19%
COPD 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Vaccine for influenza for injection into muscle 90662 Office 17 18 $1,309

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 30 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
MOUNJARO
  • Lilly USA, LLC $227
$227 27 —
AIRSUPRA
  • AstraZeneca Pharmaceuticals LP $178
$178 — —
JARDIANCE
  • Boehringer Ingelheim Pharmaceuticals, Inc. $92
  • Lilly USA, LLC $53
$144 42 —
Wegovy
  • Novo Nordisk Inc $143
$143 — —
NURTEC ODT
  • PFIZER INC. $114
$114 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 30 with Patron

Records

396 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record